The Turkish Lira has slipped 45 percent against the USD in 2018.
Shaily's 14-year long relationship with a Swedish home furnishing major should help it capitalise on the latter's aggressive growth plans for the Indian market
In terms of profits, the aggregate performance of companies witnessed a sharp improvement and increased by 32 percent Y-o-Y vis-à-vis a decline of 12.3 percent registered in Q1 FY18.
The company also said its board in a meeting held yesterday has approved raising a total fund of up to Rs 2,950 crore through issue of shares or equity linked instrument and optionally convertible debentures.
"The company reported a healthy increase of 17 per cent in its PAT to Rs 106.31 crore for Q1FY19, as compared to Rs 91.16 crore in the corresponding quarter of last fiscal. The company's Q1FY19 PAT margin stood at 16.14 per cent, as compared to 16.39 per cent in Q1FY18," the company said in a statement.
The deal now needs a go ahead from Competition Commission of India (CCI) to be consummated.
The company had posted a net profit of Rs 210.95 crore for the same period a year ago, Cox & Kings said in a filing to BSE. Consolidated total income from operations stood at Rs 2,201.58 crore for the reported quarter. It was Rs 1,922.62 crore in the year-ago period.
Total income in the reported quarter stood at Rs 272.25 crore. It was Rs 1,642.11 crore in the year-ago quarter, Videocon Industries said in a BSE filing.
All geographies have seen growth from a delivery perspective. Traditionally focused on the administrative side of healthcare business. Would like to go to to the medical side, where HGS can help improve outcome and reduce the cost of medical care.
Revenues rose 16.7 percent to Rs 7423.9 crores in Q1FY19 compared to Rs 6360.8 crore in the year ago period.
Total income rose to Rs 23.84 crore in the reported quarter from Rs 22.42 crore a year ago.
Sun Pharma's US-listed subsidiary Taro Pharmaceutical Industries' sales for the June quarter fell 4.2 percent on year to $154.6 million
The company's profit from continuing operations after tax stood at Rs 236.52 crore in the corresponding quarter last year, the company said in a release.
Its net profit stood at Rs 44.33 crore in the year-ago period, the company said in a regulatory filing.
Its total income rose to Rs 1,035.38 crore during the quarter under review as against Rs 997.12 crore in the year-ago period.
Total income, however, dropped to Rs 2,992.52 crore during the first quarter of 2018-19 from Rs 3,280.18 crore in the corresponding period of the previous year.
The company had posted a net profit of Rs 5.79 crore for the corresponding period previous fiscal, AstraZeneca Pharma India said in a BSE filing.
Loan book outstanding saw a growth of 13 percent to Rs 1,00,980.5 crore during the quarter under review as against Rs 76,224.8 crore in the year-ago period.
Revenues grew by 11 percent to Rs 394.7 crore during April-June period of the current fiscal as against Rs 355.26 crore in the corresponding period of the previous year.
Net profit in the first quarter of current fiscal rose to Rs 703.22 crore, or Rs 6.20 per share, from Rs 450.24 crore, or Rs 3.84 a share, in the same period of previous financial year, the company said in a regulatory filing.
The PAT was Rs 62.23 crore against Rs 37.82 crore made during the corresponding period last year. For the year ending March 31, 2018, the consolidated PAT was Rs 155.51 crore.
Revenue during April-June 2018 rose 32.3 per cent to Rs 336 crore, Satin Creditcare said in a statement.
Total revenues of the TVS Group company for the quarter ending June 30, 2018 grew to Rs 746.28 crore as compared to Rs 611.05 crore registered during the year-ago period.
The company had posted a net profit of Rs 58.69 crore during the same period of the previous financial year.
Total income also increased to Rs 224.96 crore in the April-June period of the current fiscal compared to Rs 135.45 crore in the corresponding quarter previous year.